AndrewPlodkowskiMD

PubMed

• 3 citations
  Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
  Danish Memon, Adam J Schoenfeld, Darwin Ye, George Fromm, Hira Rizvi, Xiang Zhang, Mohamed Reda Keddar, Divij Mathew, Kyung Jin Yoo, Jingya Qiu, Jayon Lihm, Jayalaksmi...> ;Cancer Cell. 2024 Feb 12
• 2 citations
  Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
  Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, Teng Fei, Hannah L Kalvin, Jacklynn V Egger, Hira Rizvi, Rohit Thummalapalli, Guiseppe Lamberti, Andrew Plodkowski, Ma...> ;The Oncologist. 2023 Nov 2
• Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy.
  Tahj A Blow, Anirudh Murthy, Rahul Grover, Emily Schwitzer, David M Nanus, Darragh Halpenny, Andrew J Plodkowski, Lee W Jones, Marcus D Goncalves> ;European Urology Open Science. 2023 Nov 1
• 3 citations
  Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
  Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, Daniel Muldoon, Hira Rizvi, Arielle Elkrief, Jia Luo, Joao V Alessi, Federica Pecci, Giuseppe Lamberti, Ale...> ;Clinical Cancer Research. 2023 Nov 1
• 1 citations
  The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.
  Noura J Choudhury, Jessica A Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira Rizvi, Kathryn C Arbour, Karissa Whiting, Ronglai Shen, Matthew H...> ;Clinical Cancer Research. 2023 Sep 1
• Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.
  Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G Kris, Gregory J ...> ;Clinical Cancer Research. 2023 Apr 14
• Detection of COVID-19 pulmonary manifestations with radiotherapy simulation CT imaging.
  Abraham J Wu, Andrew Plodkowski, Michelle Ginsberg, Jacob Shin, Quincey LaPlant, Annemarie Shepherd, Narek Shaverdian, Victor Ng, Daphna Gelblum, Lior Braunstein, Andr...> ;Clinical Imaging. 2023 Jan 1
• 3 citations
  Immune check-point inhibitor-related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease.
  Saira Imran, Andrew Golden, Marc Feinstein, Andrew Plodkowski, Francis Bodd, Natasha Rekhtman, William D Travis, Diane E Stover, Jennifer L Sauter> ;Histopathology. 2022 Dec 1
• 5 citations
  Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
  Paul K Paik, Pang-Dian Fan, Besnik Qeriqi, Azadeh Namakydoust, Bobby Daly, Linda Ahn, Rachel Kim, Andrew Plodkowski, Ai Ni, Jason Chang, Rachel Fanaroff, Marc Ladanyi,...> ;Journal of Thoracic Oncology. 2023 Apr 1
• 10 citations
  Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer.
  Adam J Schoenfeld, Hira A Rizvi, Danish Memon, Narek Shaverdian, Matthew J Bott, Jennifer L Sauter, C Jillian Tsai, Jayon Lihm, David Hoyos, Andrew J Plodkowski, Rocio...> ;Clinical Cancer Research. 2022 Sep 1
• 8 citations
  Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors.
  James P Solomon, Soo-Ryum Yang, Noura J Choudhury, Ryan N Ptashkin, Nasrin Eslamdoost, Christina J Falcon, Axel Martin, Andrew Plodkowski, Clare Wilhelm, Ronglai Shen,...> ;Clinical Cancer Research. 2022 Nov 1
• 102 citations
  Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-...
  Vaz, V., Biagio Ricciuti, Xinan Wang, Joao V Alessi, Hira Rizvi, Navin R Mahadevan, Yvonne Y Li, Andrew Polio, James Lindsay, Renato Umeton, Rileen Sinha, Natalie I Vo...> ;JAMA Oncology. 2022 Aug 1
• 16 citations
  Deciphering radiological stable disease to immune checkpoint inhibitors.
  J Luo, S Wu, H Rizvi, Q Zhang, J V Egger, J C Osorio, A J Schoenfeld, A J Plodkowski, M S Ginsberg, M K Callahan, C Maher, A N Shoushtari, M A Postow, M H Voss, R R Ko...> ;Annals of Oncology. 2022 Aug 1
• 10 citations
  Immune biomarkers and response to checkpoint inhibition of BRAFand BRAF non-V600 altered lung cancers.
  Yonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, Jessica R Flynn, Joseph Montecalvo, Natasha Rekhtman, Darragh Halpenny, Andrew J Plodkowski, Stephanie L Wu, Ma...> ;British Journal of Cancer. 2022 Apr 1
• 118 citations
  Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status.
  Vaz, V., Biagio Ricciuti, Kathryn C. Arbour, Jessica J. Lin, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong, Jianjun Zhang, Michael Y. Tolstorukov, Yvonne Y. Li, Liam F. S...> ;Journal of Thoracic Oncology. 2021 Nov 2
• 2 citations
  Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for ...
  Sandra Huicochea Castellanos, Andrew Pagano, Andrew J. Plodkowski, Jeffrey Girshman, Matthew D. Hellmann, Hira Rizvi, Jessica Flynn, Junting Zheng, Marinela Capanu, Da...> ;Lung Cancer. 2021 Nov 1
• 5 citations
  COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes?
  Rocio Perez-Johnston, Jose de Arimateia Batista Araujo-Filho, Natalie Gangai, Andrew J. Plodkowski, Corinne Liu, Peter Sawan, Ying Taur, Sejal Morjaria, Michelle S. Gi...> ;European Radiology. 2021 Oct 30
• 24 citations
  Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung Cancer
  Jia Luo, Victoria Martucci, Zoe Quandt, Stefan Groha, Megan H. Murray, Christine M. Lovly, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, Mohsen Abu-Akeel, Isabe...> ;Clinical Cancer Research. 2021 Sep 15
• 16 citations
  Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers.
  Noura J. Choudhury, Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang, Christina Falcon, Andrew Do, Yunan Nie, Andrew J. Plodkowski, Jamie...> ;JTO Clinical and Research Reports. 2021 Jul 1
• 19 citations
  Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics.
  Laura Mezquita, Isabel Ruth Preeshagul, Edouard Auclin, Diana Saravia, Lizza E.L. Hendriks, Hira Rizvi, Wungki Park, Ernest Nadal, Patricia Martin-Romano, Jose Carlos ...> ;European Journal of Cancer. 2021 Jul 1
• 6 citations
  Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor av...
  Angel T. Chan, William Dinsfriend, Jiwon Kim, Brian Yum, Razia Sultana, Christopher A. Klebanoff, Andrew J. Plodkowski, Rocio Perez Johnston, Michelle S. Ginsberg, Jen...> ;Journal of Cardiovascular Magnetic Resonance. 2021 Apr 5
• 4 citations
  Waxing and waning pattern of mTOR inhibitor-associated pneumonitis in renal cell carcinoma patients: A retrospective observational study.
  Jill Gluskin, Andrew J. Plodkowski, Jeffrey Girshman, Debra M. Sarasohn, Ainhoa Viteri-Jusué, Sumar Hayan, Jean Torrisi> ;Clinical Imaging. 2021 Mar 1
• 48 citations
  Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer.
  Kathryn C. Arbour, Hira Rizvi, Andrew J. Plodkowski, Matthew D. Hellmann, Andrea Knezevic, Glenn Heller, Helena A. Yu, Marc Ladanyi, Mark G. Kris, Maria E. Arcila, Cha...> ;Clinical Cancer Research. 2021 Feb 8
• 3 citations
  Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold stand...
  Jose de Arimateia Batista Araujo-Filho, Jason C. Chang, Maria Mayoral, Andrew J. Plodkowski, Rocio Perez-Johnston, Stephanie Lobaugh, Junting Zheng, Valerie W. Rusch, ...> ;Lung Cancer. 2021 Jan 25
• 31 citations
  Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade
  Kathryn C. Arbour, Anh Tuan Luu, Jia Luo, Hira Rizvi, Andrew J. Plodkowski, Mustafa Sakhi, Kevin B. Huang, Subba R. Digumarthy, Michelle S. Ginsberg, Jeffrey Girshman,...> ;Cancer Discovery. 2021 Jan 1
• Join now to see all

Journal Articles

• PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers  
  G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology